Pavan Asalapuram

I am a global health-focused biotech entrepreneur with over two decades of experience in developing and scaling diagnostic technologies that address some of the world’s most pressing socio-economic health challenges — particularly drug resistance in zoonotic infections, oral health, and antimicrobial resistance (AMR).

As an entrepreneur, I have led the development of scientifically rigorous, commercially viable, and globally deployable diagnostic and hygiene solutions such as mfloDx™, RAR-ELISA™, SelektaDx™, SteriPOC™, InstaCoat™, and OralAura™. These platforms enable rapid, accurate, and affordable detection of MDR-TB, AMR, cancer, and veterinary infections across diverse healthcare settings. I have established strategic academic, R&D, and commercial partnerships across Asia, Africa, and Europe.

I combine scientific innovation with operational execution — translating concepts into regulated, market-ready products integrated within real-world health systems. I am actively open to collaborations and partnerships with academicians and researchers in global health, and remain committed to scaling high-impact solutions in diagnostics, life sciences, health systems, and policy implementation in diagnostics and drug resistance.

My core research and innovation interests include the development of novel and impactful diagnostic solutions, with a strong focus on antibiotic resistance in tuberculosis and zoonotic infections, as well as biofilm-mediated resistance in oral hygiene. I specialize in antigen–antibody-based technologies such as lateral flow assays and ELISA, and actively explore the socio-economic dimensions of global public health interventions.

Supervised around 20 Bachelors and Masters thesis students/projects.

Conducted laboratory practical classess for Bachelor and Masters degree students.